Evidence map›Paper›PMID 10906193›Full record

ArticleJournal of virology2000

Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.

D T Evans, P Jing, T M Allen, D H O'Connor, H Horton, J E Venham, M Piekarczyk, J Dzuris, M Dykhuzen, J Mitchen and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MHC Class I Ligands of Rhesus Macaque Killer Cell Ig-like Receptors.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  6. Article
  7. Article
  8. Mechanisms of CD8European journal of immunology · 2018
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

D T EvansWisconsin Regional Primate Research Center, University of Wisconsin, Madison, Wisconsin 53715, USA.
P Jing
T M Allen
D H O'Connor
H Horton
J E Venham
M Piekarczyk
J Dzuris
M Dykhuzen
J Mitchen
R A Rudersdorf
C D Pauza
A Sette
R E Bontrop
R DeMars
D I Watkins
Primate Conservation · USUniversity of Wisconsin–Madison · USLaboratory of Molecular Genetics · PLAutoimmune Technologies (United States) · USBiomedical Primate Research Centre · NL

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
CTLS AND MHC IN RESISTANCE TO SIV IN VIVOR01AI041913 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI WATKINS, DAVID I · 1997 to 1999
–
MHC DEFINED AND MHC IDENTICAL PRIMATES FOR AIDS RESEARCHR21AI042641 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI WATKINS, DAVID I · 1997 to 1998
–
THE MHC OF THE RHESUS MONKEYR29AI032426 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI WATKINS, DAVID I · 1992 to 1996
–
NCRR NIH HHS P51 RR000167NIAID NIH HHS AI32426NIAID NIH HHS AI41913NIAID NIH HHS AI42641
6 · The paper itself

Abstract

Simian immunodeficiency virus (SIV) infection of the rhesus macaque is currently the best animal model for AIDS vaccine development. One limitation of this model, however, has been the small number of cytotoxic T-lymphocyte (CTL) epitopes and restricting major histocompatibility complex (MHC) class I molecules available for investigating virus-specific CTL responses. To identify new MHC class I-restricted CTL epitopes, we infected five members of a family of MHC-defined rhesus macaques intravenously with SIV. Five new CTL epitopes bound by four different MHC class I molecules were defined. These included two Env epitopes bound by Mamu-A*11 and -B*03 and three Nef epitopes bound by Mamu-B*03, -B*04, and -B*17. All four restricting MHC class I molecules were encoded on only two haplotypes (b or c). Interestingly, resistance to disease progression within this family appeared to be associated with the inheritance of one or both of these MHC class I haplotypes. Two individuals that inherited haplotypes b and c separately survived for 299 and 511 days, respectively, while another individual that inherited both haplotypes survived for 889 days. In contrast, two MHC class I-identical individuals that did not inherit either haplotype rapidly progressed to disease (survived <80 days). Since all five offspring were identical at their Mamu-DRB loci, MHC class II differences are unlikely to account for their patterns of disease progression. These results double the number of SIV CTL epitopes defined in rhesus macaques and provide evidence that allelic differences at the MHC class I loci may influence rates of disease progression among AIDS virus-infected individuals.

Indexed as

Amino Acid SequenceAnimalsDisease ProgressionEpitope MappingEpitopes, T-LymphocyteGene Products, envGene Products, nefHistocompatibility Antigens Class IMacaca mulattaMolecular Sequence DataSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocytes, CytotoxicViral LoadViral ProteinsEpitopes, T-LymphocyteGene Products, envGene Products, nefHistocompatibility Antigens Class IViral Proteins

Identifiers

PMID10906193
PMCPMC112260
OpenAlexW2126325079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.